Cargando…
Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression
PURPOSE: According to a few recent studies, the clinical phenotype of Graves’ disease (GD) at onset is becoming milder in recent years, in terms of prevalence and severity of hyperthyroidism, goiter and overt eye disease. The aim of this study was to assess the change in GD phenotype across the late...
Autores principales: | Ippolito, S., Cusini, C., Lasalvia, P., Gianfagna, F., Veronesi, G., Gallo, D., Masiello, E., Premoli, P., Sabatino, J., Mercuriali, A., Lai, A., Piantanida, E., Tanda, M. L., Bartalena, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285314/ https://www.ncbi.nlm.nih.gov/pubmed/33346898 http://dx.doi.org/10.1007/s40618-020-01479-z |
Ejemplares similares
-
Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
por: Bartalena, Luigi, et al.
Publicado: (2020) -
Regulatory T Cells in the Pathogenesis of Graves’ Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2023) -
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020) -
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020) -
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
por: Gallo, Daniela, et al.
Publicado: (2023)